Literature DB >> 4150738

BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.

G Mathé, O Halle-Pannenko, C Bourut.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4150738

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN： 0083-1921


× No keyword cloud information.
  6 in total

1.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

2.  The effect of BCG-vaccination on vaccinia virus infections in mice.

Authors:  G T Werner
Journal:  Experientia       Date:  1979-11-15

Review 3.  Effects of Mycobacterium bovis Calmette et Guérin (BCG) in oncotherapy: Bladder cancer and beyond.

Authors:  Neelam Mukherjee; Esther Julián; Jordi B Torrelles; Robert S Svatek
Journal:  Vaccine       Date:  2021-10-07       Impact factor: 4.169

4.  Current status of immunotherapy of human cancers: leukaemias, lymphomas, solid tumours.

Authors:  G Mathé
Journal:  Drugs       Date:  1974       Impact factor: 9.546

5.  Increased incidence of lung metastases of sarcoma 276 bearing XVII/Berlin mice after total body irradiation and BCG.

Authors:  W Arnold; A Graffi
Journal:  Clin Exp Metastasis       Date:  1983 Apr-Jun       Impact factor: 5.150

6.  Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors.

Authors:  S Tsuji; M Matsumoto; O Takeuchi; S Akira; I Azuma; A Hayashi; K Toyoshima; T Seya
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.